Who Paid My Doc
Kendall Carll
Orthopaedic Surgery of the Spine Plano, TX Medical Doctor
NPI 1063596997 CMS profile 139157
8080 Independence Pkwy Ste 230, Suite 230, Plano, TX 75025
General payments
$138,101
Research payments
$0
Ownership & investment interest
$494,012
Through program year 2025, Kendall Carll of Plano, TX is reported in the CMS Open Payments database as having received $138,101 across 32 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $494,012 across 6 holdings.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 80th percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
13 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $2,644 | 6 | |
| 2024 | General | $41,622 | 5 | |
| 2023 | General | $29,684 | 5 | |
| 2022 | General | $20,696 | 5 | |
| 2021 | General | $7,790 | 5 | |
| 2020 | General | $35,651 | 5 | |
| 2019 | General | $14 | 1 | |
| 2025 | Ownership | $47,006 | 1 | |
| 2024 | Ownership | $47,006 | 1 | |
| 2023 | Ownership | $100,000 | 1 | |
| 2022 | Ownership | $100,000 | 1 | |
| 2021 | Ownership | $100,000 | 1 | |
| 2020 | Ownership | $100,000 | 1 |
Beside peers
- Kendall Carll
- Orthopaedic Surgery of the Spine median
- Middle half of Orthopaedic Surgery of the Spine
- National median
In program year 2025, general payments to Kendall Carll were reported at $2,644. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.
Show as a table
| Year | Kendall Carll | Orthopaedic Surgery of the Spine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $14 | $2,106 | $337–$18,608 | $163 |
| 2020 | $35,651 | $1,213 | $156–$15,082 | $114 |
| 2021 | $7,790 | $1,834 | $271–$15,617 | $132 |
| 2022 | $20,696 | $2,015 | $320–$17,036 | $149 |
| 2023 | $29,684 | $1,925 | $336–$14,599 | $160 |
| 2024 | $41,622 | $2,110 | $341–$12,483 | $164 |
| 2025 | $2,644 | $2,061 | $347–$14,651 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
32 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Orthopaedic Surgery of the Spine in Texas
Randall Dryer
Orthopaedic Surgery of the Spine · Austin, TX
Craig Kuhns
Orthopaedic Surgery of the Spine · Austin, TX
David Wimberley
Orthopaedic Surgery of the Spine · Houston, TX
Jeffrey Phelps
Orthopaedic Surgery of the Spine · North Richland Hills, TX
Eric Wieser
Orthopaedic Surgery of the Spine · Arlington, TX
Andrew Clavenna
Orthopaedic Surgery of the Spine · Dallas, TX
Related records
Orthopaedic Surgery of the Spine in Texas
Practitioners in the same specialty and state, ranked by reported value.
All Orthopaedic Surgery of the Spine
Everyone recorded under this specialty, nationwide.
Doctors in Texas
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.